IP Valuation of Pharmaceutical R&D Firm

Healthcare

Instruction

AMCO was instructed by an R&D pharmaceutical firm developing treatments for rare diseases. The company required an IP valuation to support licensing agreements with larger pharmaceutical companies interested in co-developing its pipeline.

AMCO Process

AMCO Approach

We evaluated the company’s patents, clinical data, and unique formulations. Our team conducted an analysis of potential market size, regulatory pathways, and revenue from orphan drug designation to arrive at a fair valuation.

Read More

Expected

Client Outcome

The valuation facilitated licensing agreements with established pharmaceutical companies, allowing the firm to increase its R&D funding and accelerate drug development for rare disease treatments.

Learn More

Contact

Get In Touch



    I consent to my data being used in accordance with the Privacy Policy.

    I consent to my personal data being collected and stored for the purpose of marketing communications


    AMCO Agency Limited

    Contact Us

    London Office

    First Floor, 85 Great Portland Street, London, W1W 7LT

    New York Office

    3rd Floor, 1178 Broadway, New York, NY 10001, United States

    Get in Touch
    Linkedin

    Links

    Copyright © AMCO AGENCY LTD | All Rights Reserved | Website by Dentify Digital